Trump Administration Expands Drug Discount Program to 800+ Medications
TrumpRx expands to 800+ medications with 16 pharma companies, claiming $400M in savings.
Event / Politics
President Trump announced a major expansion of the TrumpRx.gov prescription drug discount program, increasing discounted medications to over 800 through most-favored-nation pricing agreements with 16 pharmaceutical companies including Eli Lilly and Novo Nordisk in exchange for tariff exemptions.
2026-08-16 to 2026-11-13 · UTC publication dates
Coverage begins 7 Jun, 04:06 UTC
Follow the documented timeline or explore the related reporting.
The Trump administration finalized most-favored-nation pricing agreements with 16 major pharmaceutical companies. Participating drugmakers received tariff-related exemptions in exchange for lowering prices on certain medications and extending discounted pricing to eligible cash-paying consumers through TrumpRx.
Major pharmaceutical companies including Eli Lilly and Novo Nordisk are participating in the TrumpRx program and have agreed to reduce prices on popular GLP-1 weight-loss medications, along with discounts on inhalers, HIV treatments, diabetes medications, and fertility drugs.
The Trump administration claims that the most-favored-nation pricing deals established through TrumpRx have already saved American patients over 400 million dollars since the program's launch.
President Donald Trump announced an expansion of the TrumpRx.gov program, adding 160 prescription drugs to bring the total number of discounted medications available to over 800. The website provides discounted pricing for approximately four out of five prescriptions filled by Americans.
TrumpRx expands to 800+ medications with 16 pharma companies, claiming $400M in savings.